Revised Code of Washington
Wash. Rev. Code § 69.50.204 (2026)
Schedule I
✓ current as of May 2026
Find cases:
SyfertCases citing this section
WA-LEGapp.leg.wa.gov
JustiaTitle on Justia
CornellLII Search
CasesGoogle Scholar
Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in Schedule I:
(a) [(1)] Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
(1) [(a)] Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(2) [(b)] Acetylmethadol;
(3) [(c)] Allylprodine;
(4) [(d)] Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
(5) [(e)] Alphameprodine;
(6) [(f)] Alphamethadol;
(7) [(g)] Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide); (1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
(8) [(h)] Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(9) [(i)] Benzethidine;
(10) [(j)] Betacetylmethadol;
(11) [(k)] Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(12) [(l)] Beta-hydroxy-3-methylfentanyl, some trade or other names: N-[1-(2-hydrox-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
(13) [(m)] Betameprodine;
(14) [(n)] Betamethadol;
(15) [(o)] Betaprodine;
(16) [(p)] Clonitazene;
(17) [(q)] Dextromoramide;
(18) [(r)] Diampromide;
(19) [(s)] Diethylthiambutene;
(20) [(t)] Difenoxin;
(21) [(u)] Dimenoxadol;
(22) [(v)] Dimepheptanol;
(23) [(w)] Dimethylthiambutene;
(24) [(x)] Dioxaphetyl butyrate;
(25) [(y)] Dipipanone;
(26) [(z)] Ethylmethylthiambutene;
(27) [(aa)] Etonitazene;
(28) [(bb)] Etoxeridine;
(29) [(cc)] Furethidine;
(30) [(dd)] Hydroxypethidine;
(31) [(ee)] Ketobemidone;
(32) [(ff)] Levomoramide;
(33) [(gg)] Levophenacylmorphan;
(34) [(hh)] 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylprop anamide);
(35) [(ii)] 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(36) [(jj)] Morpheridine;
(37) [(kk)] MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
(38) [(ll)] Noracymethadol;
(39) [(mm)] Norlevorphanol;
(40) [(nn)] Normethadone;
(41) [(oo)] Norpipanone;
(42) [(pp)] Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);
(43) [(qq)] PEPAP(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
(44) [(rr)] Phenadoxone;
(45) [(ss)] Phenampromide;
(46) [(tt)] Phenomorphan;
(47) [(uu)] Phenoperidine;
(48) [(vv)] Piritramide;
(49) [(ww)] Proheptazine;
(50) [(xx)] Properidine;
(51) [(yy)] Propiram;
(52) [(zz)] Racemoramide;
(53) [(aaa)] Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide);
(54) [(bbb)] Tilidine;
(55) [(ccc)] Trimeperidine.
(b) [(2)] Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, including their salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) [(a)] Acetorphine;
(2) [(b)] Acetyldihydrocodeine;
(3) [(c)] Benzylmorphine;
(4) [(d)] Codeine methylbromide;
(5) [(e)] Codeine-N-Oxide;
(6) [(f)] Cyprenorphine;
(7) [(g)] Desomorphine;
(8) [(h)] Dihydromorphine;
(9) [(i)] Drotebanol;
(10) [(j)] Etorphine, except hydrochloride salt;
(11) [(k)] Heroin;
(12) [(l)] Hydromorphinol;
(13) [(m)] Methyldesorphine;
(14) [(n)] Methyldihydromorphine;
(15) [(o)] Morphine methylbromide;
(16) [(p)] Morphine methylsulfonate;
(17) [(q)] Morphine-N-Oxide;
(18) [(r)] Myrophine;
(19) [(s)] Nicocodeine;
(20) [(t)] Nicomorphine;
(21) [(u)] Normorphine;
(22) [(v)] Pholcodine;
(23) [(w)] Thebacon.
(c) [(3)] Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation. For the purposes of this subsection only, the term "isomer" includes the optical, position, and geometric isomers:
(1) [(a)] Alpha-ethyltryptamine: Some trade or other names: Etryptamine; monase; a-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; a-ET; and AET;
(2) [(b)] 4-bromo-2,5-dimethoxy-amphetamine: Some trade or other names: 4-bromo-2,5-dimethoxy-a-methylphenethylamine; 4-bromo-2,5-DMA;
(3) [(c)] 4-bromo-2,5-dimethoxyphenethylamine: Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, nexus;
(4) [(d)] 2,5-dimethoxyamphetamine: Some trade or other names: 2,5-dimethoxy-a-methylphenethylamine; 2,5-DMA;
(5) [(e)] 2,5-dimethoxy-4-ethylamphetamine (DOET);
(6) [(f)] 2,5-dimethoxy-4-(n)-propylthiophenethylamine: Other name: 2C-T-7;
(7) [(g)] 4-methoxyamphetamine: Some trade or other names: 4-methoxy-a-methylphenethylamine; paramethoxyamphetamine, PMA;
(8) [(h)] 5-methoxy-3,4-methylenedioxy-amphetamine;
(9) [(i)] 4-methyl-2,5-dimethoxy-amphetamine: Some trade and other names: 4-methyl-2,5-dimethoxy-a-methylphenethylamine; "DOM"; and "STP";
(10) [(j)] 3,4-methylenedioxy amphetamine;
(11) [(k)] 3,4-methylenedioxymethamphetamine (MDMA);
(12) [(l)] 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
(13) [(m)] N-hydroxy-3,4-methylenedioxyamphetamine also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine,N-hydroxy MDA;
(14) [(n)] 3,4,5-trimethoxy amphetamine;
(15) [(o)] Alpha-methyltryptamine: Other name: AMT;
(16) [(p)] Bufotenine: Some trade or other names: 3-(beta-Dimethylaminoethyl)-5-hydroxindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
(17) [(q)] Cannabis;
(18) [(r)] Diethyltryptamine: Some trade or other names: N,N-Diethyltryptamine; DET;
(19) [(s)] Dimethyltryptamine: Some trade or other names: DMT;
(20) [(t)] 5-methoxy-N,N-diisopropyltryptamine: Other name: 5-MeO-DIPT;
(21) [(u)] Ibogaine: Some trade or other names: 7-Ethyl-6,6 beta,7,8,9,10,12,13,-octahydro-2-methoxy-6,9-methano-5H-pyndo (1',2' 1,2) azepino (5,4-b) indole; Tabernanthe iboga;
(22) [(v)] Lysergic acid diethylamide;
(23) [(w)] Mescaline;
(24) [(x)] Parahexyl-7374: Some trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo[b,d]pyran; synhexyl;
(25) [(y)] Peyote, meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds, or extracts; (interprets 21 U.S.C. Sec. 812 (c), Schedule I (c)(12));
(26) [(z)] N-ethyl-3-piperidyl benzilate;
(27) [(aa)] N-methyl-3-piperidyl benzilate;
(28) [(bb)] Psilocybin;
(29) [(cc)] Psilocyn;
(30) [(dd)](i) Tetrahydrocannabinols, meaning tetrahydrocannabinols naturally contained in a plant of the genera Cannabis, as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of the genera Cannabis, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:
(A) 1 - cis - or trans tetrahydrocannabinol, and their optical isomers, excluding tetrahydrocannabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the United States Food and Drug Administration;
(B) 6 - cis - or trans tetrahydrocannabinol, and their optical isomers;
(C) 3,4 - cis - or trans tetrahydrocannabinol, and its optical isomers; or
(D) That is chemically synthesized and either:
(I) Has been demonstrated to have binding activity at one or more cannabinoid receptors; or
(II) Is a chemical analog or isomer of a compound that has been demonstrated to have binding activity at one or more cannabinoid receptors;
(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)
(ii) Hemp and industrial hemp, as defined in RCW 15.140.020, are excepted from the categories of controlled substances identified under this section;
(31) [(ee)] Ethylamine analog of phencyclidine: Some trade or other names: N-ethyl-1phenylcyclohexalymine, (1-phenylcyclohexl) ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE;
(32) [(ff)] Pyrrolidine analog of phencyclidine: Some trade or other names: 1-(1-phencyclohexyl)pyrrolidine; PCPy; PHP;
(33) [(gg)] Thiophene analog of phencyclidine: Some trade or other names: 1-(1-[2-thenyl]-cyclohexly)-pipendine; 2-thienylanalog of phencyclidine; TPCP; TCP;
(34) [(hh)] 1-[1-(2-thienyl)cyclohexyl]pyrrolidine: A trade or other name is TCPy.
(d) [(4)] Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
(1) [(a)] Gamma-hydroxybutyric acid: Some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate;
(2) [(b)] Mecloqualone;
(3) [(c)] Methaqualone.
(e) [(5)] Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1) [(a)] Aminorex: Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4, 5-dihydro-5-phenly-2-oxazolamine;
(2) [(b)] N-Benzylpiperazine: Some other names: BZP,1-benzylpiperazine;
(3) [(c)] Cathinone, also known as 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone and norephedrone;
(4) [(d)] Fenethylline;
(5) [(e)] Methcathinone: Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of optical isomers;
(6) [(f)] (+-)cis-4-methylaminorex ((+-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
(7) [(g)] N-ethylamphetamine;
(8) [(h)] N,N-dimethylamphetamine: Some trade or other names: N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenoethylene.
The controlled substances in this section may be added, rescheduled, or deleted as provided for in RCW 69.50.201.
[ 2022 c 16 s 53; 2019 c 158 s 13; 2015 2nd sp.s. c 4 s 1203; 2010 c 177 s 2; 1993 c 187 s 4; 1986 c 124 s 3; 1980 c 138 s 1; 1971 ex.s. c 308 s 69.50.204.]
Notes:
Intent—Finding—2022 c 16: See note following RCW 69.50.101.
Effective date—2019 c 158: See RCW 15.140.900.
Findings—Intent—Effective dates—2015 2nd sp.s. c 4: See notes following RCW 69.50.334.
Pharmacy quality assurance commission may change schedules of controlled substances: RCW 69.50.201.
Notes of Decisions
Cited in 85
cases (11 in the last 5 years), 1973–2026 · leading case: Seeley v. State, 940 P.2d 604 (Wash. 1997).
Seeley v. State, 940 P.2d 604 (Wash. 1997). “The State appeals a decision of the Pierce County Superior Court holding that RCW 69.50.204(c)(14), which places marijuana in Schedule I of controlled substances, is unconstitutional, violating art.”
State v. McDougal, 841 P.2d 1232 (Wash. 1992). “873 (1980), this court, in discussing the statute as it applied to possession or delivery of marijuana, a schedule 1 offense, RCW 69.50.204(d)(13), for crimes committed before July 1, 1984, stated that: The statute does not expressly designate the offense a felony, but rather…”
State v. Patterson, 679 P.2d 416 (Wash. Ct. App. 1984). “He points to other sections of the statute that specifically describe natural plants that contain controlled substances, such as RCW 69.50.204(d)(13) (marijuana) and (d)(15) (peyote), and RCW 69.”
State v. Atchley, 142 Wash. App. 147 (Wash. Ct. App. 2007). “¶51 RCW 69.50.204(c)(14) lists marijuana as a schedule I controlled substance.”
State v. Silva-Baltazar, 886 P.2d 138 (Wash. 1994). “410 by selling for profit any controlled substance or counterfeit substance classified in schedule I, RCW 69.50.204, except leaves and flowering tops of marihuana to a person in a school or on a school bus .”
State v. Reis, 351 P.3d 127 (Wash. 2015). “However, in 1998, the legislature enacted the MUCA, chapter 69.51 A RCW, creating an exception for the medicinal use of marijuana.”
State v. Dickamore, 592 P.2d 681 (Wash. Ct. App. 1979). “2 RCW 69.50.204 provides, in part: "(a) The controlled substances listed in this section are included in Schedule I.”
State v. Zillyette, 307 P.3d 712 (Wash. 2013). “RCW 69.50.204. RCW 69.50.206. RCW 69.50.208.”
State v. DeVries, 72 P.3d 748 (Wash. 2003). “RCW 69.50.204(c)(7). The trial judge found that while the deputy’s testimony was weak, and standing alone would probably not have been sufficient to establish knowledge, it was still a factor in his deliberation.”
State v. Hugdahl, 458 P.3d 760 (Wash. 2020). “401 by manufacturing, selling, delivering, or possessing with the intent to manufacture, sell, or deliver a controlled substance listed under that subsection by selling for profit any controlled substance or counterfeit substance classified in schedule I, RCW 69.50.204, except…”
State v. Tibbles, 236 P.3d 885 (Wash. 2010). “See former RCW 69.50.204(14) (1993); RCW 69.50.401(2)(c); RCW 69.”
State v. Sibert, 230 P.3d 142 (Wash. 2010). “518 (seriousness level I applies to delivery of or possession with intent to deliver marijuana); RCW 69.50.204(c)(14) (marijuana listed in schedule I); former RCW 69.”
— Wash. Rev. Code § 69.50.204(14) — 1 case
State v. Tibbles, 236 P.3d 885 (Wash. 2010). “See former RCW 69.50.204(14) (1993); RCW 69.50.401(2)(c); RCW 69.”
— Wash. Rev. Code § 69.50.204(a) — 2 cases
State v. Halsten, 108 Wash. App. 759 (Wash. Ct. App. 2001).
State v. Halsten, 33 P.3d 751 (Wash. Ct. App. 2001).
— Wash. Rev. Code § 69.50.204(b) — 1 case
State of Washington v. Eric Allen Haggin (Wash. Ct. App. 2016).
— Wash. Rev. Code § 69.50.204(b)(11) — 5 cases
State v. Peterson, 498 P.3d 937 (Wash. 2021).
State Of Washington, Resp. v. James Master Ocain, App. (Wash. Ct. App. 2016).
State Of Washington v. Carlos Lima (Wash. Ct. App. 2018).
State Of Washington, V. John Canales (Wash. Ct. App. 2022).
State Of Washington, V. Richard James Rotter (Wash. Ct. App. 2025).
— Wash. Rev. Code § 69.50.204(b)(13) — 1 case
State v. Hinton, 280 P.3d 476 (Wash. Ct. App. 2012).
— Wash. Rev. Code § 69.50.204(c) — 6 cases
State v. Phelps, 118 Wash. App. 740 (Wash. Ct. App. 2003).
State v. Smith, 552 P.2d 1059 (Wash. Ct. App. 1976).
State v. Perry, 516 P.2d 1104 (Wash. Ct. App. 1973).
State v. Swain, 520 P.2d 950 (Wash. Ct. App. 1974).
State of Washington v. Maxwell Delvon Jones (Wash. Ct. App. 2017).
— Wash. Rev. Code § 69.50.204(c)(13) — 1 case
State v. Vanoli, 937 P.2d 1166 (Wash. Ct. App. 1997).
— Wash. Rev. Code § 69.50.204(c)(14) — 17 cases
Seeley v. State, 940 P.2d 604 (Wash. 1997). “The State appeals a decision of the Pierce County Superior Court holding that RCW 69.50.204(c)(14), which places marijuana in Schedule I of controlled substances, is unconstitutional, violating art.”
State v. Atchley, 142 Wash. App. 147 (Wash. Ct. App. 2007). “¶51 RCW 69.50.204(c)(14) lists marijuana as a schedule I controlled substance.”
State v. Sibert, 230 P.3d 142 (Wash. 2010). “518 (seriousness level I applies to delivery of or possession with intent to deliver marijuana); RCW 69.50.204(c)(14) (marijuana listed in schedule I); former RCW 69.”
State v. Tibbles, 169 Wash. 2d 364 (Wash. 2010).
State v. Miller, 929 P.2d 372 (Wash. 1997).
— Wash. Rev. Code § 69.50.204(c)(17) — 5 cases
Stewart v. Extra Space Storage (W.D. Wash. 2024).
State Of Washington, V. Paul Thomas Clark (Wash. Ct. App. 2025).
Pers. Restraint Petition of Wendell Maurice Clark (Wash. Ct. App. 2024).
State Of Washington, V. Paul Thomas Clark (Wash. Ct. App. 2025).
State of Washington v. Edwin Juarez Del Rio (Wash. Ct. App. 2026).
— Wash. Rev. Code § 69.50.204(c)(22) — 14 cases
State v. Reis, 351 P.3d 127 (Wash. 2015). “However, in 1998, the legislature enacted the MUCA, chapter 69.51 A RCW, creating an exception for the medicinal use of marijuana.”
Seeley v. State, 940 P.2d 604 (Wash. 1997). “The State appeals a decision of the Pierce County Superior Court holding that RCW 69.50.204(c)(14), which places marijuana in Schedule I of controlled substances, is unconstitutional, violating art.”
State of Washington v. Thomas Lee Weatherwax, 193 Wash. App. 667 (Wash. Ct. App. 2016).
State v. Reis, 322 P.3d 1238 (Wash. Ct. App. 2014).
State Of Washington v. Anthony G. Houck, 446 P.3d 646 (Wash. Ct. App. 2019).
— Wash. Rev. Code § 69.50.204(c)(30) — 1 case
Pers. Restraint Petition Of Clifton Kelly Bell (Wash. Ct. App. 2025).
— Wash. Rev. Code § 69.50.204(c)(7) — 2 cases
State v. DeVries, 72 P.3d 748 (Wash. 2003). “RCW 69.50.204(c)(7). The trial judge found that while the deputy’s testimony was weak, and standing alone would probably not have been sufficient to establish knowledge, it was still a factor in his deliberation.”
State v. DeVries, 72 P.3d 748 (Wash. 2003).
— Wash. Rev. Code § 69.50.204(d) — 5 cases
State v. Dickamore, 592 P.2d 681 (Wash. Ct. App. 1979). “2 RCW 69.50.204 provides, in part: "(a) The controlled substances listed in this section are included in Schedule I.”
State v. Sherman, 547 P.2d 1234 (Wash. Ct. App. 1976).
State v. Martin, 544 P.2d 750 (Wash. Ct. App. 1976).
State v. Cowles, 538 P.2d 840 (Wash. Ct. App. 1975).
State v. Palmer, 637 P.2d 239 (Wash. 1981).
— Wash. Rev. Code § 69.50.204(d)(10) — 2 cases
State v. McGinley, 573 P.2d 30 (Wash. Ct. App. 1977).
State v. Jones, 610 P.2d 934 (Wash. Ct. App. 1980).
— Wash. Rev. Code § 69.50.204(d)(13) — 4 cases
State v. McDougal, 841 P.2d 1232 (Wash. 1992). “873 (1980), this court, in discussing the statute as it applied to possession or delivery of marijuana, a schedule 1 offense, RCW 69.50.204(d)(13), for crimes committed before July 1, 1984, stated that: The statute does not expressly designate the offense a felony, but rather…”
Seeley v. State, 940 P.2d 604 (Wash. 1997). “The State appeals a decision of the Pierce County Superior Court holding that RCW 69.50.204(c)(14), which places marijuana in Schedule I of controlled substances, is unconstitutional, violating art.”
State v. Patterson, 679 P.2d 416 (Wash. Ct. App. 1984). “He points to other sections of the statute that specifically describe natural plants that contain controlled substances, such as RCW 69.50.204(d)(13) (marijuana) and (d)(15) (peyote), and RCW 69.”
Seeley v. State, 940 P.2d 604 (Wash. 1997).
— Wash. Rev. Code § 69.50.204(d)(18) — 1 case
State v. Patterson, 679 P.2d 416 (Wash. Ct. App. 1984). “He points to other sections of the statute that specifically describe natural plants that contain controlled substances, such as RCW 69.50.204(d)(13) (marijuana) and (d)(15) (peyote), and RCW 69.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.